These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20635112)

  • 1. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.
    Mandolesi G; Grasselli G; Musumeci G; Centonze D
    Neurol Sci; 2010 Nov; 31(Suppl 2):S255-9. PubMed ID: 20635112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I; Swiątkiewicz M; Zaremba M; Cudna A; Piechal A; Pyrzanowska J; Widy-Tyszkiewicz E; Członkowska A
    Neuroscience; 2013 Sep; 248():690-8. PubMed ID: 23806721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
    Centonze D; Muzio L; Rossi S; Cavasinni F; De Chiara V; Bergami A; Musella A; D'Amelio M; Cavallucci V; Martorana A; Bergamaschi A; Cencioni MT; Diamantini A; Butti E; Comi G; Bernardi G; Cecconi F; Battistini L; Furlan R; Martino G
    J Neurosci; 2009 Mar; 29(11):3442-52. PubMed ID: 19295150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in autoimmune CNS inflammation.
    Herz J; Zipp F; Siffrin V
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Musella A; Gentile A; Guadalupi L; Rizzo FR; De Vito F; Fresegna D; Bruno A; Dolcetti E; Vanni V; Vitiello L; Bullitta S; Sanna K; Caioli S; Balletta S; Nencini M; Buttari F; Stampanoni Bassi M; Centonze D; Mandolesi G
    Cells; 2020 May; 9(5):. PubMed ID: 32455907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis.
    Mandolesi G; Gentile A; Musella A; Centonze D
    Cerebellum; 2015 Feb; 14(1):19-22. PubMed ID: 25326653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
    Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Nisticò R; Mori F; Feligioni M; Nicoletti F; Centonze D
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130162. PubMed ID: 24298163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
    Nisticò R; Mango D; Mandolesi G; Piccinin S; Berretta N; Pignatelli M; Feligioni M; Musella A; Gentile A; Mori F; Bernardi G; Nicoletti F; Mercuri NB; Centonze D
    PLoS One; 2013; 8(1):e54666. PubMed ID: 23355887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
    Centonze D; Muzio L; Rossi S; Furlan R; Bernardi G; Martino G
    Cell Death Differ; 2010 Jul; 17(7):1083-91. PubMed ID: 19927157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
    Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
    Skundric DS
    Curr Neurovasc Res; 2005 Oct; 2(4):349-62. PubMed ID: 16181126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
    Soellner IA; Rabe J; Mauri V; Kaufmann J; Addicks K; Kuerten S
    Clin Immunol; 2013 Dec; 149(3):519-29. PubMed ID: 24239839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosis.
    Di Filippo M; de Iure A; Giampà C; Chiasserini D; Tozzi A; Orvietani PL; Ghiglieri V; Tantucci M; Durante V; Quiroga-Varela A; Mancini A; Costa C; Sarchielli P; Fusco FR; Calabresi P
    Sci Rep; 2016 Feb; 6():20926. PubMed ID: 26887636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
    J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
    Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
    Guadalupi L; Mandolesi G; Vanni V; Balletta S; Caioli S; Pavlovic A; De Vito F; Fresegna D; Sanna K; Vitiello L; Nencini M; Tartacca A; Mariani F; Rovella V; Schippling S; Ruf I; Collin L; Centonze D; Musella A
    Neuropharmacology; 2024 Jul; 252():109940. PubMed ID: 38570068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.